Diagnosis and management of nail psoriasis;Aspectos diagnósticos y terapéuticos de la psoriasis ungueal

Actas Dermo-Sifiliograficas

Volumn 99, Issue 1, 2008, Pages 34-43

  Sánchez Regaña, Manuel ^a   Umbert, P ^b  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b NONE

Author keywords

Diagnosis; Management; Nails; Psoriasis

Indexed keywords

CYCLOSPORIN; RETINOL DERIVATIVE; VITAMIN D DERIVATIVE;

HUMAN; MORBIDITY; MYCOSIS; NAIL; NAIL BED; PREVALENCE; PSORIASIS; PSORIATIC ARTHRITIS; REVIEW;

ALGORITHMS; HUMANS; NAIL DISEASES; PSORIASIS;

EID: 39049115002     PISSN: 00017310     EISSN: 15782190     Source Type: Journal    
DOI: 10.1016/S1578-2190(08)70192-6     Document Type: Article

References (30)

1. De Jong EMGJ, Seegers BA, Gulinck MK, Boezeman JB, van de Kekhof PC. Psoriasis of the nails associated with disability in a large number of patients: results of a recent interview with 1728 patients. Dermatology. 1996;193:300-3.
2. Sánchez Regaña M, Iglesias M, Creus L, Umbert P. Prevalencia de enfermedades hepáticas crónicas en pacientes con psoriasis. Actas Dermosifiliogr. 2000;91:498-510.
3. Tosti A, Morelli R, Bardazzi, Piraccini BM. Psoriasis of the nails. En: Dubertret L, editor. Psoriasis. Brescia: ISED; 1994. p. 201-7.
4. Lawry M. Biological therapy and nail psoriasis. Dermatologic Therapy. 2007;20:60-7.
5. Sánchez Regaña M, Ojeda R, Umbert I, Umbert P, Lupo W, Solé J. El impacto psicosocial de la psoriasis. Actas Dermosifiliogr. 2003;94:11-6.
6. Duhard-Brohan E. Psoriasis unguéal. Ann Dermatol Venereol. 1999;126:445-9.
7. Rudolph RL. Lithium-induced psoriasis of the fingernails. J Am Acad Dermatol. 1992; 26:135-6.
8. Szepes E. Mycotic nail fold infections of psoriatic nails. Mykosen. 1986;29:82-4.
9. Gupta AK, Lynde CW, Jain HC, Sibbald RG, Elewski BE, Daniel CR, et al. A higher prevalence of onychomycosis in psoriatics compared with non-psoriatics: a multicentre study. Br J Dermatol. 1997;136:786-9.
10. Sánchez Regaña M, Videla S, Villoria J, Domingo E, Macaya A, Ortiz E, et al. Report on the prevalence of fungal involvement in a series of patients with nail psoriasis. Clin Exp Dermatol. En prensa 2007.
11. Rich PH, Scher RK. Nail psoriasis severity index: a useful tool for evaluation of nail psoriasis. J Am Acad Dermatol. 2003;49:206-12.
12. Parrish CA, Sobera JO, Elewski BE. Modification of the nail psoriasis severity index. J Am Acad Dermatol. 2005;53: 745-7.
13. De Berker D. Management of nail psoriasis. Clin Exp Dermatol. 2000;25:357-62.
14. Baran R, Tosti A. Topical treatment of nail psoriasis with a new corticoid-containing nail lacquer formulation. J Dermatol Treat. 1999;10:201-4.
15. Sánchez Regaña M, Martín G, Umbert P, Llambí F. Treatment of nail psoriasis with 8% clobetasol nail lacquer: positive experience in 10 patients. JEADV. 2005;19:573-7.
16. García-Navarro X, Serra-Baldrich E, Roé E, Corella F, Dalmau J, Barco D, et al. Acute onset of «green nails» after treatment with 8% clobetasol nail lacquer. Proceedings of the 16th European Academy of Dermatology and Venereology; 2007, mayo 16-20; Viena.
17. Sánchez Regaña M, Ojeda R, Umbert P. Empleo de calcipotriol tópico en la psoriasis ungueal. Piel. 2002;17:104-8.
18. Rigopoulos D, Loannides D, Prastitis N, Katsambas A. Nail psoriasis: a combined treatment using calcipotriol cream and clobetasol propionate cream. Acta Derm Venereol. 2002;82: 140.
19. Márquez G, Sánchez Regaña M, Herrera E, Vidal I, Galvany L, Umbert P. Tratamiento de la psoriasis ungueal con laca de clobetasol 8% y ungüento de tacalcitol. Proceedings of the XXXV Congreso Nacional de la Academia Española de Dermatología y Venereología; 2007, junio 13-16; Granada.
20. Bianchi L, Soda R, Diluvio L, Chimenti S. Tazarotene 0,1% gel for psoriasis of the fingernails and toenails: an open prospective study. Br J Dermatol. 2003;149:207-9.
21. Scher RK, Stiller M, Zhu YI. Tazarotene 0,1% gel in the treatment of fingernails psoriasis: a double-blind, randomized, vehicle-controlled study. Cutis. 2001;68:355-8.
22. Rigopoulos D, Gregoriou S, Katsambas A. Treatment of psoriatic nails with taza rotene cream 0,1% vs. clobetasol propionate 0,05% cream: a double-blind study. Acta Derm Venereol. 2007;87:167-8.
23. Frederiksson T. Topically applied fluorouracil in the treatment of psoriatic nails. Arch Dermatol. 1974;110:735.
24. Fritz K. Psoriasis of the nails. Successful topical treatment with 5-fluorouracil. Z Hautkr. 1988;64:1083-8.
25. Yamamoto T, Katayama I, Nishioka K. Topical anthralin therapy for refractory nail psoriasis. J Dermatol. 1988;25:231-3.
26. Tosti A, Guerra L, Bardazzi F, Lanzarini M. Topical ciclosporin in nail psoriasis. Dermatológica. 1990;180:110.
27. Ojeda R, Sánchez Regaña M, Massana J, Oliete R, Umbert P. Clinical experience with the use of cyclosporin A in psoriasis. Results of a retrospective study. J Dermatol Treat. 2005;16:338-41.
28. Mahrle G, Schulze HJ, Faerber L, Weidinger G, Steigleder GK. Low -dose short-term ciclosporin versus etretinate in psoriasis: improvement of skin, nail, and joint involvement. J Am Acad Dermatol. 1995;32:78-88.
29. Herrera E, Sánchez Regaña M, Vidal I, Galvany L, Márquez G, Molinero J, et al. Efalizumab: experiencia en la psoriasis. Proceedings of the XXXV Congreso Nacional de la Academia Española de Dermatología y Venereología; 2007, junio 13-16; Granada.
30. Vidal I, Sánchez Regaña M, Herrera E, Galvany L, Márquez G, Umbert P. Etanercept: seguimiento durante 2 años en pacientes con psoriasis. Proceedings of the XXXV Congreso Nacional de la Academia Española de Dermatología y Venereología; 2007, junio 13-16; Granada.